SCHEMBL3277146

SCHEMBL3277146

ClP(c1ccccc1)c1cccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.41
CYP1A2 P05177 4/20 0.41
ALDH1A1 P00352 7/20 0.39
HSD17B10 Q99714 5/20 0.39
TSHR P16473 3/20 0.39
TDP1 Q9NUW8 3/20 0.39
CYP3A4 P08684 3/20 0.37
HPGD P15428 3/20 0.37
KEAP1 Q14145 1/20 0.37
NR4A1 P22736 1/20 0.36
NR4A2 P43354 1/20 0.36
NR4A3 Q92570 1/20 0.36
HPRT1 P00492 1/20 0.36
CDC25B P30305 2/20 0.35
TP53 P04637 1/20 0.35
ALOX15 P16050 1/20 0.35
ATM Q13315 1/20 0.35
PAX8 Q06710 1/20 0.34
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2516404 0.87 CYP1A2 (0.48) CYP2A6CYP1A2ALDH1A1HSD17B10TSHR
SCHEMBL8033180 0.79 TDP1 (0.45) ALDH1A1HSD17B10TSHRTDP1CYP3A4
SCHEMBL30170447 0.78 CYP3A4 (0.48) CYP2A6CYP1A2ALDH1A1HSD17B10TSHR
SCHEMBL132132 0.78 CYP3A4 (0.48) CYP2A6CYP1A2ALDH1A1HSD17B10TSHR
SCHEMBL29440576 0.78 CYP3A4 (0.48) CYP2A6CYP1A2ALDH1A1HSD17B10TSHR
SCHEMBL7569519 0.78 CYP3A4 (0.48) CYP2A6CYP1A2ALDH1A1HSD17B10TSHR
SCHEMBL133687 0.78 CYP3A4 (0.48) CYP2A6CYP1A2ALDH1A1HSD17B10TSHR
SCHEMBL9327630 0.78 CYP1A2 (0.44) CYP2A6CYP1A2ALDH1A1HSD17B10TSHR
SCHEMBL2368837 0.78 CYP1A2 (0.48) CYP2A6CYP1A2ALDH1A1HSD17B10TSHR
SCHEMBL5440142 0.75 NR4A1 (0.41) CYP2A6CYP1A2ALDH1A1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114560872-B Heterocyclic imidazole compound and application thereof 上海八亿时空先进材料有限公司 2023-06-20 CN disclosed
CN-114560872-A Heterocyclic imidazole compound and application thereof 上海八亿时空先进材料有限公司 2022-05-31 CN disclosed
US-7696349-B2 Method for asymmetric synthesis BASF SE (DE) 2010-04-13 US disclosed
US-20090326226-A1 METHOD FOR ASYMMETRIC SYNTHESIS BASF AKTIENGESELLSCHAFT (DE) 2009-12-31 US disclosed
EP-1689760-B1 METHOD FOR ASYMMETRIC SYNTHESIS BASF SE (DE) 2009-10-28 EP disclosed
US-7442842-B2 Method for asymmetric synthesis BASF SE (DE) 2008-10-28 US disclosed
US-20070073092-A1 Method for asymmetric synthesis BASF AKTIENGESELLSCHAFT (DE) 2007-03-29 US disclosed
EP-1689760-A1 METHOD FOR ASYMMETRIC SYNTHESIS BASF AKTIENGESELLSCHAFT (DE) 2006-08-16 EP disclosed
WO-2005051964-A1 METHOD FOR ASYMMETRIC SYNTHESIS BASF AKTIENGESELLSCHAFT (DE) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070073092-A1 Method for asymmetric synthesis COASY, PIN1, INF2 CYP2A6 31/4885CYP1A2 127/4885ALDH1A1 2499/4885
US-20090326226-A1 METHOD FOR ASYMMETRIC SYNTHESIS COASY, PIN1, INF2 CYP2A6 31/4885CYP1A2 127/4885ALDH1A1 2499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.